Disclaimer: This article is for educational purposes only. It does not provide legal advice, does not establish an attorney-client relationship, and should not be relied on for legal decisions. Always consult a licensed attorney regarding your specific case.
Product liability litigation is the PI subset where deposition preparation most resembles patent practice — heavy on engineering documents, technical experts, and the corporate machinery that produced the product at issue. The cases are won and lost on whether the design or warning was reasonable, judged against an alternative the manufacturer could have adopted. The deposition workflow that develops the reasonableness analysis effectively does so through the manufacturer's own engineers, internal documents, and corporate testimony.
For PI attorneys whose practice includes products work, the substantive framework — Restatement (Third) of Torts: Product Liability §§ 1, 2 and the state law that has variously adopted, modified, or rejected it — drives every deposition decision. This article addresses the framework, the state-by-state divide between competing tests, and the deposition architecture that consistently produces effective testimony.
The Restatement (Third) Framework
The Restatement (Third) of Torts: Products Liability, adopted by the American Law Institute in 1998, replaced the earlier Restatement (Second) § 402A's strict-liability framework with a defect-specific approach. Three defect categories govern:
Manufacturing defect. A product departs from its intended design even though all possible care was exercised in the preparation and marketing of the product. Manufacturing defect cases turn on whether the specific unit at issue differs from the design specification.
Design defect. The foreseeable risks of harm posed by the product could have been reduced or avoided by the adoption of a reasonable alternative design, and the omission of that alternative renders the product not reasonably safe. Design defect is the most-litigated category.
Warning defect (failure to warn). The foreseeable risks of harm posed by the product could have been reduced or avoided by the provision of reasonable instructions or warnings, and the omission of those instructions or warnings renders the product not reasonably safe.
The framework's defining feature, for plaintiff's-bar purposes, is that design defect under § 2(b) requires proof of a reasonable alternative design. This is a significant departure from the pure consumer-expectation analysis some states had previously applied.
The State-Level Divide
The Restatement (Third)'s reasonable-alternative-design requirement has been the source of significant state-level disagreement. The major positions:
States adopting the Restatement (Third). A majority of states have adopted the reasonable-alternative-design framework in some form, either through explicit endorsement of the Restatement or through case-law convergence on the same analysis.
States retaining consumer-expectation analysis. Several states — California's Barker v. Lull, 20 Cal.3d 413 (1978) framework, Colorado's Camacho v. Honda line, and others — permit plaintiffs to proceed under a consumer-expectation test that does not require proof of an alternative design. The consumer-expectation test asks whether the product failed to perform as safely as an ordinary consumer would expect.
States with hybrid frameworks. Some states permit plaintiffs to elect between consumer-expectation and risk-utility theories, or apply different tests depending on the product category. Several states reserve consumer-expectation analysis for products whose ordinary use is simple enough that lay juries can evaluate safety expectations directly.
The threshold case-law analysis determines what the deposition has to develop. In a reasonable-alternative-design jurisdiction, the deposition must develop a specific alternative design and the manufacturer's awareness of it. In a consumer-expectation jurisdiction, the deposition develops the gap between actual product performance and ordinary consumer expectations.
The Design Engineer Deposition
The design engineer — typically the manufacturer's employee or former employee who participated in the product's design — is often the most consequential deposition in a product case. The areas that produce usable testimony:
The design history. Walk the engineer through the product's design evolution. Initial concept, design review meetings, prototype testing, design modifications. The deposition develops what the design alternatives considered were and why specific choices were made.
The hazard analysis. Most manufacturers conduct some form of hazard analysis — FMEA (Failure Modes and Effects Analysis), FTA (Fault Tree Analysis), or similar — during product development. The deposition develops whether the hazard at issue was identified in the analysis, what the manufacturer's response was, and whether the response was implemented in the final design.
The trade-off analysis. Design choices involve trade-offs between cost, safety, performance, and manufacturability. The deposition develops what trade-offs were made and on what basis. Documents typically show explicit cost-benefit analyses; the engineer's testimony either confirms the analyses or undermines them.
The alternative-design knowledge. Did the engineer know of alternative designs that addressed the hazard? Were any considered? Were any prototyped? Were any in use by competitors? Were any required by industry standards the manufacturer was aware of? This is where the reasonable-alternative-design framework either lives or dies.
The post-sale awareness. When did the manufacturer first become aware of incidents involving the hazard? What was the response? Did the design change as a result? Were warnings updated? Was the product recalled?
The pattern across product cases is that the design engineer's testimony often surfaces internal documents and reasoning that the manufacturer's official position substantially understates. The deposition that develops these areas with documentary anchors produces both substantive evidence and impeachment material for trial.
The Warnings Expert Deposition
Failure-to-warn cases require separate development. The framework asks whether reasonable instructions or warnings would have reduced or avoided the foreseeable harm.
The deposition outline:
Warnings methodology. What standards govern warning content, format, and placement? ANSI Z535 (the American National Standards Institute's warning standards) and various industry-specific standards supply the technical framework. The deposition develops whether the warning at issue conforms to applicable standards.
The heeding presumption. Most jurisdictions apply a heeding presumption — the assumption that the user would have heeded a warning if given. The presumption shifts the burden to the defendant to prove that the warning would not have made a difference. The deposition should develop the user's testimony about what they did and did not know, what warnings they did and did not see, and what they would have done differently with adequate warning.
Foreseeability of misuse. Many product cases involve some degree of user error or misuse. The legal question is whether the misuse was foreseeable. The deposition develops what the manufacturer knew, or should have known, about how users were actually using the product, including any complaints, lawsuits, or service records that reflected the misuse pattern.
Adequacy of the warning given. Where a warning was provided but is alleged to be inadequate, the deposition develops the warning's specific defects — conspicuousness, language, location, content. Comparison to industry standards and to competing products' warnings supports the inadequacy claim.
The Manufacturer's 30(b)(6) Deposition
The 30(b)(6) deposition of the manufacturer is where individual-engineer testimony is connected to corporate liability theories. Notice topics that earn their time:
- The manufacturer's product-development process for this specific product and product line.
- The manufacturer's awareness of incidents, complaints, or lawsuits involving the same or similar products prior to the incident at issue.
- The manufacturer's response to those incidents, including any design changes, warning changes, or recall decisions.
- The manufacturer's compliance with applicable industry standards (ANSI, ASTM, ISO, sector-specific standards).
- The manufacturer's regulatory compliance (FDA for medical devices, CPSC for consumer products, NHTSA for automotive, etc.).
- The manufacturer's post-sale duty practices — monitoring, reporting, recall procedures.
For product cases involving regulated industries, the regulatory deposition track is often more productive than the design-engineering track because it produces documents and admissions that constitute objective evidence of the manufacturer's awareness and response.
Post-Sale Duty Issues
The Restatement (Third) § 10 imposes a post-sale duty to warn under specific conditions: when the manufacturer knows or reasonably should know of the risk, when the persons to whom the warning would be issued can be identified, when the warning could be effectively communicated, and when the risk of harm is sufficiently great to justify the burden.
The deposition implications are significant. The manufacturer who learned of the hazard years before the incident at issue and failed to communicate a warning may face liability on a post-sale theory even if the original product was not defectively designed. The 30(b)(6) deposition should develop:
- When the manufacturer first became aware of the hazard.
- What information the manufacturer received from customers, dealers, repair facilities, or service organizations.
- Whether the manufacturer's regulatory reporting (e.g., FDA MedWatch, CPSC Section 15(b)) reflected the hazard.
- What corrective actions the manufacturer considered and which it implemented.
- The basis for any decision not to issue a post-sale warning or to delay the warning's issuance.
Daubert and the December 2023 FRE 702 Amendment
Product cases typically involve multiple expert witnesses on the plaintiff's side — design engineering, human factors, warnings, biomechanics — each potentially subject to Daubert. The December 2023 amendment to FRE 702 reinforced the requirement that the court determine, by a preponderance, that the expert's testimony reflects reliable application of reliable methodology.
The deposition implications:
- Plaintiff's experts should be deposed by defense counsel in significant cases. The defense Daubert motion will be informed by what the deposition develops.
- Plaintiff's-side preparation of their own experts should develop the methodology, the data, and the application chain in the deposition. An expert whose deposition testimony lacks specific methodology grounding is at higher risk under the amended rule.
- Cross-examination of defense experts should specifically target the reliable-application requirement. A defense expert who applies generally accepted methodology in a way that is not reliable in this specific case is exposed under the amendment.
Frequently Asked Questions
Does the Restatement (Third) require expert testimony in design defect cases?
Practically yes, in most cases. The reasonable-alternative-design requirement typically necessitates expert testimony to identify and validate the proposed alternative. Simple design cases involving lay-evaluable defects (e.g., a chair leg that obviously will fail under normal use) sometimes proceed without expert testimony, but most contested design cases require it.
Can a plaintiff plead both design defect and warning defect?
Yes, and most plaintiff's-side complaints do. The theories are alternative and can support different damage theories. A jury can find for the plaintiff on either or both theories. The deposition workflow should develop both theories where the facts permit.
What is the "state of the art" defense?
Some jurisdictions permit a state-of-the-art defense, which limits design defect liability to conditions known or knowable at the time of manufacture. Deposition development of when the manufacturer knew or should have known of the hazard becomes crucial in state-of-the-art jurisdictions. The defense is recognized in some states by statute and in others by common law.
How does the federal preemption analysis affect product depositions?
Federal preemption — particularly under the Federal Food, Drug, and Cosmetic Act for medical devices, the Federal Insecticide Fungicide and Rodenticide Act, and similar regulatory schemes — may foreclose certain state-law claims. The preemption analysis should be done at case intake to determine what theories are viable and what the deposition needs to develop.
Closing
Product liability cases reward the most thorough deposition preparation of any PI subset. The cases turn on the manufacturer's awareness, the design choices made, and the reasonableness of those choices judged against alternatives that existed at the time. Each of those elements is developed through documents and testimony, and the testimony is developed at deposition.
For PI firms whose practice includes products work, the deposition workflow that builds from the technical document base through the engineer-level witnesses to the corporate 30(b)(6) testimony consistently produces the strongest cases. Front-end investment in technical expert consultation, document organization, and deposition preparation is the single highest-leverage work in product litigation; the cases settle or try at the values the deposition record supports.